Perrigo Receives Binding Offer to Divest Its Hra Pharma Rare Diseases Business for up to €275 Million
Perrigo收到具有約束力的要約,將以高達2.75億歐元的價格剝離其Hra Pharma罕見病業務
Perrigo Receives Binding Offer to Divest Its Hra Pharma Rare Diseases Business for up to €275 Million
Perrigo收到具有約束力的要約,將以高達2.75億歐元的價格剝離其Hra Pharma罕見病業務
使用瀏覽器的分享功能,分享給你的好友吧